291 related articles for article (PubMed ID: 12559804)
1. Co-immunization with plasmids coding the full length and a soluble form of glycoprotein D of HSV-2 induces protective cellular and humoral immune response in mice.
Fló J
Vaccine; 2003 Mar; 21(11-12):1239-45. PubMed ID: 12559804
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules.
Fló J; Tisminetzky S; Baralle F
Immunology; 2000 Jun; 100(2):259-67. PubMed ID: 10886404
[TBL] [Abstract][Full Text] [Related]
3. Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene.
Fló J; Beatriz Perez A; Tisminetzky S; Baralle F
Vaccine; 2000 Aug; 18(28):3242-53. PubMed ID: 10869769
[TBL] [Abstract][Full Text] [Related]
4. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.
Kuklin N; Daheshia M; Karem K; Manickan E; Rouse BT
J Virol; 1997 Apr; 71(4):3138-45. PubMed ID: 9060677
[TBL] [Abstract][Full Text] [Related]
5. CCL19 and CCL28 Assist Herpes Simplex Virus 2 Glycoprotein D To Induce Protective Systemic Immunity against Genital Viral Challenge.
Yan Y; Hu K; Fu M; Deng X; Luo S; Tong L; Guan X; He S; Li C; Jin W; Du T; Zheng Z; Zhang M; Liu Y; Hu Q
mSphere; 2021 Apr; 6(2):. PubMed ID: 33910988
[TBL] [Abstract][Full Text] [Related]
6. Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice.
Fló J; Tisminetzky S; Baralle F
Vaccine; 2001 Feb; 19(13-14):1772-82. PubMed ID: 11166903
[TBL] [Abstract][Full Text] [Related]
7. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2.
Bourne N; Milligan GN; Schleiss MR; Bernstein DI; Stanberry LR
Vaccine; 1996 Sep; 14(13):1230-4. PubMed ID: 8961510
[TBL] [Abstract][Full Text] [Related]
8. Immunological properties of a DNA plasmid encoding a chimeric protein of herpes simplex virus type 2 glycoprotein B and glycoprotein D.
Domingo C; Gadea I; Pardeiro M; Castilla C; Fernández S; Fernández-Clua MA; De la Cruz Troca JJ; Punzón C; Soriano F; Fresno M; Tabarés E
Vaccine; 2003 Sep; 21(25-26):3565-74. PubMed ID: 12922084
[TBL] [Abstract][Full Text] [Related]
9. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
[TBL] [Abstract][Full Text] [Related]
10. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
[TBL] [Abstract][Full Text] [Related]
11. Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge.
Çuburu N; Wang K; Goodman KN; Pang YY; Thompson CD; Lowy DR; Cohen JI; Schiller JT
J Virol; 2015 Jan; 89(1):83-96. PubMed ID: 25320297
[TBL] [Abstract][Full Text] [Related]
12. Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge.
Yan Y; Hu K; Deng X; Guan X; Luo S; Tong L; Du T; Fu M; Zhang M; Liu Y; Hu Q
J Immunol; 2015 Jul; 195(1):329-38. PubMed ID: 25994965
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
Karem KL; Bowen J; Kuklin N; Rouse BT
J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
[TBL] [Abstract][Full Text] [Related]
14. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
Peng T; Ponce-de-Leon M; Jiang H; Dubin G; Lubinski JM; Eisenberg RJ; Cohen GH
J Virol; 1998 Jan; 72(1):65-72. PubMed ID: 9420201
[TBL] [Abstract][Full Text] [Related]
15. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes.
Konishi E; Yamaoka M; Khin-Sane-Win ; Kurane I; Takada K; Mason PW
J Virol; 1999 Jul; 73(7):5527-34. PubMed ID: 10364301
[TBL] [Abstract][Full Text] [Related]
16. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
[TBL] [Abstract][Full Text] [Related]
17. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
18. [Enhancement of herpes simplex virus-1 glycoprotein-D DNA vaccine induced specific immune responses by coimmunization with interleukin-2 genetic adjuvant].
Liu XJ; Zhu MZ; Song GX; Xu YF; Liu HW; Wang S; Yang BL; Dong FT; Xu XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):67-72. PubMed ID: 15782496
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
[TBL] [Abstract][Full Text] [Related]
20. Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus.
Lee S; Gierynska M; Eo SK; Kuklin N; Rouse BT
Microbes Infect; 2003 Jun; 5(7):571-8. PubMed ID: 12787733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
